Qihan Biotech Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 79

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $13.7M

  • Investors
  • 12

Qihan Biotech General Information

Description

Developer of biotechnological products designed for immune-privileged cell and organ therapies. The company's technology utilises multiplexable genome editing and immune shielding to produce immune-privileged cells and organs, providing healthcare providers with allogeneic and xenogeneic transplantation options to address organ shortages and treat medical conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building B, Transfar Science and Technology Innovation Building
  • Xiaoshan Science and Technology City, Xiaoshan District
  • Hangzhou, Zhejiang 311200
  • China
+86 0571
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Corporate Office
  • 5th Floor, Building B, Transfar Science and Technology Innovation Building
  • Xiaoshan Science and Technology City, Xiaoshan District
  • Hangzhou, Zhejiang 311200
  • China
+86 0571

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qihan Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 22-Sep-2023 $13.7M Completed Generating Revenue
3. Early Stage VC (Series A2) 29-Mar-2021 Completed Generating Revenue
2. Early Stage VC (Series A1) 23-Sep-2019 $25.5M $33.3M Completed Generating Revenue
1. Early Stage VC (Series A) 23-Jul-2018 $7.8M $7.8M Completed Generating Revenue
To view Qihan Biotech’s complete valuation and funding history, request access »

Qihan Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biotechnological products designed for immune-privileged cell and organ therapies. The company's technology
Biotechnology
Hangzhou, China
79 As of 2023

London, United Kingdom
 

Mont-Saint-Guibert, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Qihan Biotech Competitors (27)

One of Qihan Biotech’s 27 competitors is MiNA Therapeutics, a Venture Capital-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MiNA Therapeutics Venture Capital-Backed London, United Kingdom
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
StemiRNA Therapeutics Venture Capital-Backed Shanghai, China
Sernova Biotherapeutics Corporation Mississauga, Canada
Sangamo Therapeutics Formerly VC-backed Richmond, CA
You’re viewing 5 of 27 competitors. Get the full list »

Qihan Biotech Patents

Qihan Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024199244-A1 Systems and methods for enhanced cell therapies Inactive 27-Mar-2023
WO-2023147776-A1 Systems and methods for enhanced immunotherapies Inactive 07-Feb-2022
WO-2023147777-A1 Systems and methods for enhanced immunotherapies Inactive 07-Feb-2022
WO-2023143475-A1 Methods and compositions for cell-based immunotherapies Inactive 28-Jan-2022
WO-2023093763-A1 Systems and methods for cell-based immunotherapies cross-reference Inactive 24-Nov-2021 C07K16/2887
To view Qihan Biotech’s complete patent history, request access »

Qihan Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qihan Biotech Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Zhejiang Provincial Financial Holdings Government Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
MPC (Beijing) Venture Capital Minority
BC Global Asset Management Asset Manager Minority
CMB International Capital Asset Manager Minority
You’re viewing 5 of 12 investors. Get the full list »

Qihan Biotech FAQs

  • When was Qihan Biotech founded?

    Qihan Biotech was founded in 2017.

  • Where is Qihan Biotech headquartered?

    Qihan Biotech is headquartered in Hangzhou, China.

  • What is the size of Qihan Biotech?

    Qihan Biotech has 79 total employees.

  • What industry is Qihan Biotech in?

    Qihan Biotech’s primary industry is Biotechnology.

  • Is Qihan Biotech a private or public company?

    Qihan Biotech is a Private company.

  • What is Qihan Biotech’s current revenue?

    The current revenue for Qihan Biotech is .

  • How much funding has Qihan Biotech raised over time?

    Qihan Biotech has raised $114M.

  • Who are Qihan Biotech’s investors?

    Zhejiang Provincial Financial Holdings, LAV (Lilly Asia Fund), MPC (Beijing), BC Global Asset Management, and CMB International Capital are 5 of 12 investors who have invested in Qihan Biotech.

  • Who are Qihan Biotech’s competitors?

    MiNA Therapeutics, Cellaion, StemiRNA Therapeutics, Sernova Biotherapeutics, and Sangamo Therapeutics are some of the 27 competitors of Qihan Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process